196 related articles for article (PubMed ID: 32001406)
1. SMARCB1-Deficient Sinonasal Carcinoma: Systematic Review and Case Report.
Parsel SM; Jawad BA; McCoul ED
World Neurosurg; 2020 Apr; 136():305-310. PubMed ID: 32001406
[TBL] [Abstract][Full Text] [Related]
2. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.
Agaimy A; Hartmann A; Antonescu CR; Chiosea SI; El-Mofty SK; Geddert H; Iro H; Lewis JS; Märkl B; Mills SE; Riener MO; Robertson T; Sandison A; Semrau S; Simpson RH; Stelow E; Westra WH; Bishop JA
Am J Surg Pathol; 2017 Apr; 41(4):458-471. PubMed ID: 28291122
[TBL] [Abstract][Full Text] [Related]
3. SMARCB1/INI1-deficient sinonasal carcinoma shows methylation of RASSF1 gene: A clinicopathological, immunohistochemical and molecular genetic study of a recently described entity.
Laco J; Chmelařová M; Vošmiková H; Sieglová K; Bubancová I; Dundr P; Němejcová K; Michálek J; Čelakovský P; Mottl R; Sirák I; Vošmik M; Ryška A
Pathol Res Pract; 2017 Feb; 213(2):133-142. PubMed ID: 28069272
[TBL] [Abstract][Full Text] [Related]
4. Clinical Diagnosis and Treatment Analyses on SMARCB1 (Integrase Interactor 1)-Deficient Sinonasal Carcinoma: Case Series with Systematic Review of the Literature.
Wang R; Wang L; Fang J; Zhong Q; Hou L; Ma H; Feng L; He S; Wang C; Zhang L
World Neurosurg; 2022 May; 161():e229-e243. PubMed ID: 35123020
[TBL] [Abstract][Full Text] [Related]
5. Cytopathologic characteristics of SMARCB1 (INI-1) deficient sinonasal carcinoma: A potential diagnostic pitfall.
Allison DB; Bishop JA; Ali SZ
Diagn Cytopathol; 2016 Aug; 44(8):700-3. PubMed ID: 27177850
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of the diagnosis and treatment of patients with SMARCB1 (INI-1)-deficient sinonasal carcinoma].
Wang LW; Wang R; Fang JG; Zhong LZ; Hou HZ; Ma L; Feng SZ; He CS; Wang L; Zhang L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Jul; 57(7):848-853. PubMed ID: 35866278
[No Abstract] [Full Text] [Related]
7. Impact of Clinical Factors and Treatments on SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma.
Contrera KJ; Shakibai N; Su SY; Gule-Monroe MK; Roberts D; Brahimaj B; Williams MD; Ferrarotto R; Phan J; Gunn B; Raza S; DeMonte F; Hanna EY
Otolaryngol Head Neck Surg; 2023 Aug; 169(2):435-440. PubMed ID: 36856048
[TBL] [Abstract][Full Text] [Related]
8. SMARCB1 (INI1)-deficient sinonasal carcinoma: a series of 13 cases with assessment of histologic patterns.
Kakkar A; Antony VM; Pramanik R; Sakthivel P; Singh CA; Jain D
Hum Pathol; 2019 Jan; 83():59-67. PubMed ID: 30120966
[TBL] [Abstract][Full Text] [Related]
9. Metastatic SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma Diagnosed by Endobronchial Ultrasound-Guided Fine-Needle Aspiration (EBUS-FNA): A Potential Diagnostic Pitfall and Review of the Literature.
McHugh KE; Policarpio-Nicolas MLC
Acta Cytol; 2019; 63(5):431-437. PubMed ID: 31132763
[TBL] [Abstract][Full Text] [Related]
10. Genetic basis of SMARCB1 protein loss in 22 sinonasal carcinomas.
Dogan S; Cotzia P; Ptashkin RN; Nanjangud GJ; Xu B; Momeni Boroujeni A; Cohen MA; Pfister DG; Prasad ML; Antonescu CR; Chen Y; Gounder MM
Hum Pathol; 2020 Oct; 104():105-116. PubMed ID: 32818509
[TBL] [Abstract][Full Text] [Related]
11. SMARCB1 deficient sinonasal carcinoma: An emerging entity with a diagnostic challenge.
Anila KR; Ginju V; Vishnu VL; Kumar R; Jayasree K
Indian J Pathol Microbiol; 2023; 66(1):159-161. PubMed ID: 36656230
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy in SMARCB1 (INI-1)-deficient sinonasal carcinoma: Two case reports.
Zhang L; Gao AX; He YL; Xu MJ; Lu HJ
World J Clin Cases; 2023 Nov; 11(32):7911-7919. PubMed ID: 38073679
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation-based classification of sinonasal undifferentiated carcinoma.
Dogan S; Vasudevaraja V; Xu B; Serrano J; Ptashkin RN; Jung HJ; Chiang S; Jungbluth AA; Cohen MA; Ganly I; Berger MF; Momeni Boroujeni A; Ghossein RA; Ladanyi M; Chute DJ; Snuderl M
Mod Pathol; 2019 Oct; 32(10):1447-1459. PubMed ID: 31186531
[TBL] [Abstract][Full Text] [Related]
14. [SMARCB1 (INI1)-deficient sinonasal carcinoma: a clinicopathological analysis of six cases].
Tang SJ; Zhai CW; Yuan CC; Zhang JH; Wang SY
Zhonghua Bing Li Xue Za Zhi; 2020 Jan; 49(1):47-51. PubMed ID: 31914534
[No Abstract] [Full Text] [Related]
15. [Clinicopathological characteristics of SMARCB1(INI1)-deficient sinonasal carcinoma].
Wang JY; Bai YP; Xing L; Piao YS; He XJ; Yue CL; Zhao XL; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2021 Nov; 50(11):1240-1245. PubMed ID: 34719161
[No Abstract] [Full Text] [Related]
16. Diffuse spinal cord metastasis after resection of SMARCB1 sinonasal carcinoma manifesting with a right foot drop-a case report.
da Silva MA; Bentes RGL; Teixeira HS; Carvalho BM; Queiroz ALG; Schmid MF; Lima KDF; Ferreira WSM; Campos CMS; Neto MR; Baeta AM
Spinal Cord Ser Cases; 2022 Jul; 8(1):64. PubMed ID: 35778377
[TBL] [Abstract][Full Text] [Related]
17. SMARCA4-deficient Sinonasal Carcinoma.
Agaimy A; Weichert W
Head Neck Pathol; 2017 Dec; 11(4):541-545. PubMed ID: 28176137
[TBL] [Abstract][Full Text] [Related]
18. SMARCB1 (INI-1)-Deficient Adenocarcinoma of the Sinonasal Tract: A Potentially Under-Recognized form of Sinonasal Adenocarcinoma with Occasional Yolk Sac Tumor-Like Features.
Shah AA; Jain D; Ababneh E; Agaimy A; Hoschar AP; Griffith CC; Magliocca KR; Wenig BM; Rooper LM; Bishop JA
Head Neck Pathol; 2020 Jun; 14(2):465-472. PubMed ID: 31468350
[TBL] [Abstract][Full Text] [Related]
19. SMARCB1/INI1 Deficient Sino-Nasal Carcinoma: Extending the Histomorphological Features.
Ayyanar P; Mishra P; Preetam C; Adhya AK
Head Neck Pathol; 2021 Jun; 15(2):555-565. PubMed ID: 33141418
[TBL] [Abstract][Full Text] [Related]
20. SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma: A Case Report and Literature Review.
Yang H; Zhou L; Zhong G; Li X; Wang Y
Ear Nose Throat J; 2022 May; ():1455613221082622. PubMed ID: 35603532
[No Abstract] [Full Text] [Related]
[Next] [New Search]
